CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
133 hedge funds and large institutions have $485M invested in Cymabay Therapeutics in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 29 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $907M → $485M (-$422M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
133
Holding in Top 10
2
Calls
$7.81M
Puts
$1.28M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$14.1M | |
| 3 | +$9.18M | |
| 4 |
Citigroup
New York
|
+$4.03M |
| 5 |
BlackRock
New York
|
+$3.53M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$13.3M | |
| 3 | -$11.1M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$7.97M |
| 5 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$7.32M |